WO2003057072A3 - Hemostatic compositions and methods for controlling bleeding - Google Patents

Hemostatic compositions and methods for controlling bleeding Download PDF

Info

Publication number
WO2003057072A3
WO2003057072A3 PCT/US2002/041748 US0241748W WO03057072A3 WO 2003057072 A3 WO2003057072 A3 WO 2003057072A3 US 0241748 W US0241748 W US 0241748W WO 03057072 A3 WO03057072 A3 WO 03057072A3
Authority
WO
WIPO (PCT)
Prior art keywords
hemostatic compositions
methods
controlling bleeding
polysaccharide
article
Prior art date
Application number
PCT/US2002/041748
Other languages
French (fr)
Other versions
WO2003057072A8 (en
WO2003057072A2 (en
Inventor
Kent C Cochrum
Susan Jemtrud
Original Assignee
Ares Lab Llc
Kent C Cochrum
Susan Jemtrud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Lab Llc, Kent C Cochrum, Susan Jemtrud filed Critical Ares Lab Llc
Priority to AU2002361902A priority Critical patent/AU2002361902A1/en
Priority to EP02797532A priority patent/EP1469865A4/en
Priority to JP2003557435A priority patent/JP2005514105A/en
Priority to MXPA04006438A priority patent/MXPA04006438A/en
Priority to CA002471994A priority patent/CA2471994A1/en
Publication of WO2003057072A2 publication Critical patent/WO2003057072A2/en
Publication of WO2003057072A3 publication Critical patent/WO2003057072A3/en
Publication of WO2003057072A8 publication Critical patent/WO2003057072A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.
PCT/US2002/041748 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding WO2003057072A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2002361902A AU2002361902A1 (en) 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding
EP02797532A EP1469865A4 (en) 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding
JP2003557435A JP2005514105A (en) 2001-12-31 2002-12-31 Hemostasis composition and method for controlling bleeding
MXPA04006438A MXPA04006438A (en) 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding.
CA002471994A CA2471994A1 (en) 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34324701P 2001-12-31 2001-12-31
US60/343,247 2001-12-31
US35491702P 2002-02-11 2002-02-11
US60/354,917 2002-02-11

Publications (3)

Publication Number Publication Date
WO2003057072A2 WO2003057072A2 (en) 2003-07-17
WO2003057072A3 true WO2003057072A3 (en) 2003-10-30
WO2003057072A8 WO2003057072A8 (en) 2004-07-08

Family

ID=26993389

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/041748 WO2003057072A2 (en) 2001-12-31 2002-12-31 Hemostatic compositions and methods for controlling bleeding

Country Status (7)

Country Link
US (3) US7101862B2 (en)
EP (1) EP1469865A4 (en)
JP (1) JP2005514105A (en)
AU (1) AU2002361902A1 (en)
CA (1) CA2471994A1 (en)
MX (1) MXPA04006438A (en)
WO (1) WO2003057072A2 (en)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941498D1 (en) * 1998-11-12 2009-11-12 Internat Mfg Group Inc Hemostatic cross-linked dextran beads useful for rapid blood clotting and hemostasis
US20070009586A1 (en) * 2000-02-29 2007-01-11 Cohen Kelman I Wound dressings containing complexes of transition metals and alginate for elastase sequestering
US6891077B2 (en) * 2001-07-25 2005-05-10 The United States Of America As Represented By The Secretary Of The Army Fibrinogen bandages and arterial bleeding models and methods of making and using thereof
US7670623B2 (en) 2002-05-31 2010-03-02 Materials Modification, Inc. Hemostatic composition
WO2005027808A1 (en) 2003-09-12 2005-03-31 Z-Medica Corporation Calcium zeolite hemostatic agent
ATE489062T1 (en) * 2003-09-12 2010-12-15 Z Medica Corp PARTIALLY HYDROGENATED HEMOSTATIC AGENT
US20050136773A1 (en) * 2003-12-22 2005-06-23 Kimberly-Clark Worldwide, Inc. Treated nonwoven material
US7737214B2 (en) * 2004-03-15 2010-06-15 Terumo Kabushiki Kaisha Adhesion preventive material
SE0403070D0 (en) * 2004-12-16 2004-12-16 Radi Medical Systems Closure Device
US20060178609A1 (en) * 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
JP2008531498A (en) 2005-02-15 2008-08-14 バージニア コモンウェルス ユニバーシティ Mineral technology (MT) for emergency hemostasis and treatment of acute wounds and chronic ulcers
US9326995B2 (en) 2005-04-04 2016-05-03 The Regents Of The University Of California Oxides for wound healing and body repair
US20060282046A1 (en) * 2005-04-13 2006-12-14 Horn Jeffrey L Device and method for subcutaneous delivery of blood clotting agent
EP1741453A3 (en) 2005-07-07 2007-01-17 Nipro Corporation Collagen substrate, method of manufacturing the same, and method of using the same
EP1960009B1 (en) 2005-12-13 2011-11-23 The President and Fellows of Harvard College Scaffolds for cell transplantation
GB2433205A (en) * 2005-12-16 2007-06-20 Ethicon Inc Wound dressing comprising a strong cation exchange resin
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8938898B2 (en) 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7968114B2 (en) * 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US20070276308A1 (en) * 2006-05-26 2007-11-29 Huey Raymond J Hemostatic agents and devices for the delivery thereof
US20080014251A1 (en) * 2006-07-14 2008-01-17 Advanced Vascular Dynamics Hemostatic compound and its use
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
CN100453122C (en) * 2006-09-29 2009-01-21 沈晶 Hemostatic micro-granules and its prepn. method
US8414550B2 (en) * 2006-09-29 2013-04-09 Lexion Medical, Llc System and method to vent gas from a body cavity
US8551139B2 (en) 2006-11-30 2013-10-08 Cook Medical Technologies Llc Visceral anchors for purse-string closure of perforations
EP2150183B1 (en) 2007-05-31 2013-03-20 Cook Medical Technologies LLC Suture lock
WO2009002401A2 (en) 2007-06-21 2008-12-31 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
US20090162406A1 (en) * 2007-09-05 2009-06-25 Z-Medica Corporation Wound healing with zeolite-based hemostatic devices
WO2009060439A2 (en) * 2007-11-05 2009-05-14 Technion - Research & Development Foundation Ltd Adhesives and methods of applying the same
CA2709337A1 (en) * 2007-12-20 2009-07-02 The University Of Queensland Haemostasis- modulating compositions and uses therefor
CN104888264B (en) 2008-01-14 2018-01-09 北京环球利康科技有限公司 Biocompatible hemostatic, prevent adhesion, the modified starch material of promoting healing, surgery closing
WO2009102787A2 (en) * 2008-02-12 2009-08-20 Boston Scientific Scimed, Inc. Medical implants with polysaccharide drug eluting coatings
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
US10328133B2 (en) 2008-02-13 2019-06-25 President And Fellows Of Harvard College Continuous cell programming devices
US8585646B2 (en) 2008-03-03 2013-11-19 Lexion Medical, Llc System and method to vent gas from a body cavity
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
US9707251B2 (en) 2008-03-11 2017-07-18 Materials Modification, Inc. Siloxane-based artificial blockage to control bleeding
MX338212B (en) 2008-04-11 2016-04-07 Univ Virginia Commonwealth Electrospun dextran fibers and devices formed therefrom.
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
US20090275904A1 (en) * 2008-05-02 2009-11-05 Sardesai Neil Rajendra Sheet assemblies with releasable medicaments
AU2009244462B2 (en) 2008-05-06 2013-04-11 Cook Medical Technologies Llc Apparatus and methods for delivering therapeutic agents
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
WO2010053737A1 (en) * 2008-10-29 2010-05-14 Wilson-Cook Medical, Inc. Endoscopic sheet delivery
AU2009324646B2 (en) * 2008-12-11 2013-02-14 Cook Medical Technologies Llc Endoscopic sheet rolling system
WO2010074949A1 (en) 2008-12-23 2010-07-01 Wilson-Cook Medical Inc. Apparatus and methods for containing and delivering therapeutic agents
US8647368B2 (en) 2009-04-03 2014-02-11 Cook Medical Technologies Llc Tissue anchors and medical devices for rapid deployment of tissue anchors
WO2010120749A2 (en) 2009-04-13 2010-10-21 President And Fellow Of Harvard College Harnessing cell dynamics to engineer materials
WO2010136588A2 (en) 2009-05-28 2010-12-02 Profibrix B.V. Dry powder fibrin sealant
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
WO2010140146A2 (en) 2009-06-01 2010-12-09 Technion - Research & Development Foundation Ltd Sealants, manufacturing thereof, and applications thereof
AU2010278702C1 (en) 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
EP2542230A4 (en) 2010-03-05 2013-08-28 Harvard College Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
US20110237994A1 (en) * 2010-03-25 2011-09-29 Combat Medical Systems, Llc Void-filling wound dressing
EP2585053A4 (en) 2010-06-25 2014-02-26 Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
KR102155383B1 (en) 2010-10-06 2020-09-11 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Injectable, pore-forming hydrogels for materials-based cell therapies
WO2012057751A1 (en) * 2010-10-27 2012-05-03 Empire Technology Development Llc Crosslinked cellulosic polymers
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
WO2012148684A1 (en) 2011-04-27 2012-11-01 President And Fellows Of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
WO2012149358A1 (en) 2011-04-28 2012-11-01 President And Fellows Of Harvard College Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
AU2012261848B2 (en) 2011-06-03 2017-06-15 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
WO2013052577A1 (en) * 2011-10-04 2013-04-11 Z-Medica, Llc Hemostatic fibrous material
US20130096479A1 (en) 2011-10-18 2013-04-18 St. Teresa Medical, Inc. Method of forming hemostatic products
CN102551896B (en) * 2012-01-19 2013-08-07 河南科技大学 Disposable counting brain cotton aseptic package tray
PT2838515T (en) 2012-04-16 2020-02-25 Harvard College Mesoporous silica compositions for modulating immune responses
KR101945031B1 (en) 2012-06-22 2019-02-01 지-메디카 엘엘씨 Hemostatic devices
US9649330B2 (en) * 2013-01-17 2017-05-16 Thomas Barrows Hydrogel tattoo protection and aftercare system
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US10016524B2 (en) 2013-04-11 2018-07-10 President And Fellows Of Harvard College Prefabricated alginate-drug bandages
GB2514592A (en) * 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
US9555157B2 (en) 2013-11-12 2017-01-31 St. Teresa Medical, Inc. Method of inducing hemostasis in a wound
JP7348708B2 (en) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Combination vaccine device and method for killing cancer cells
ES2864658T3 (en) 2014-05-05 2021-10-14 Advanced Medical Solutions Israel Sealantis Ltd Biological adhesives and sealants and methods of using them
US10137219B2 (en) 2014-08-04 2018-11-27 James F. Drake Coherent blood coagulation structure of water-insoluble chitosan and water-dispersible starch coating
EP3250250A4 (en) 2015-01-30 2019-05-22 President and Fellows of Harvard College Peritumoral and intratumoral materials for cancer therapy
US11150242B2 (en) 2015-04-10 2021-10-19 President And Fellows Of Harvard College Immune cell trapping devices and methods for making and using the same
EP3344299B1 (en) * 2015-09-01 2021-08-11 Baxter International Inc Hemostatic material
CN108430526B (en) 2015-11-08 2021-08-10 奥姆里克斯生物药品有限公司 Hemostatic mixture of cellulose-based short and long fibers
WO2017083050A1 (en) 2015-11-12 2017-05-18 St. Teresa Medical, Inc. A method of sealing a durotomy
US11752238B2 (en) 2016-02-06 2023-09-12 President And Fellows Of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
JP2019522486A (en) 2016-07-13 2019-08-15 プレジデント アンド フェローズ オブ ハーバード カレッジ Antigen presenting cell mimetic scaffold and methods for making and using the same
CA3033757A1 (en) * 2016-10-11 2018-04-19 St. Teresa Medical, Inc. Hemostatic products
US20180110735A1 (en) * 2016-10-20 2018-04-26 Bard Access Systems, Inc. Antimicrobial alginate-based microparticles and related materials and methods
US10953130B2 (en) 2017-08-31 2021-03-23 Victor Matthew Phillips Solid hemostatic composition and methods of making the same
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
EP3717028A1 (en) * 2017-11-28 2020-10-07 Baxter International Inc Wound-treating absorbent
CN108144128B (en) * 2018-02-07 2021-11-05 陕西佰傲再生医学有限公司 Multi-time cross-linking breast patch and preparation method thereof
CN109125790A (en) * 2018-08-25 2019-01-04 山东康力医疗器械科技有限公司 A kind of styptic sponge structure made of chitosan

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543410A (en) * 1982-06-21 1985-09-24 Morca, Inc. Absorbent cellulosic base structures
US5081041A (en) * 1990-04-03 1992-01-14 Minnesota Mining And Manufacturing Company Ionic component sensor and method for making and using same
US5902877A (en) * 1994-09-21 1999-05-11 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent of interleukins, process for removing the same, and adsorber for the same
WO2000076533A1 (en) * 1999-06-10 2000-12-21 Fusion Medical Technologies, Inc. Hemoactive compositions and methods for their manufacture and use
WO2001005370A1 (en) * 1999-07-16 2001-01-25 Samyang Corporation Antiadhesion barriers containing water-soluble alginate and carboxymethyl cellulose as major components and preparation method thereof

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27327A (en) * 1860-02-28 Improvement in apparatus for distilling coal-oil
US854715A (en) * 1905-10-26 1907-05-28 Gen Electric Combined coupling and bearing.
US959080A (en) * 1908-08-05 1910-05-24 Samuel B Sheldon Process for coking coal.
US974054A (en) * 1910-01-20 1910-10-25 Frank Guy Acetylene-lamp.
US1454055A (en) * 1920-04-17 1923-05-08 Klamroth Wilfried Razor-blade holder
US2387642A (en) 1942-03-25 1945-10-23 Calhoun Vernon Hemostat and method of forming same
US3206361A (en) 1962-06-19 1965-09-14 Johnson & Johnson Stabilized methylaminoacetocatechol hemostatic wound dressing
US3507851A (en) 1966-03-24 1970-04-21 Victor Ghetie Synthesis derivatives of agarose having application in electrophoresis on gel and in chromatography
US3671280A (en) * 1970-12-04 1972-06-20 David F Smith Plaster of paris bandages to make casts of improved strength,water-resistance and physiological properties
DE2247163A1 (en) 1972-09-26 1974-03-28 Merck Patent Gmbh CARRIER MATRIX FOR FIXING BIOLOGICALLY ACTIVE SUBSTANCES AND THE PROCESS FOR THEIR PRODUCTION
US3810473A (en) 1972-12-04 1974-05-14 Avicon Inc Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties
FR2234311B1 (en) 1973-06-21 1976-04-30 Air Liquide
DE2644678A1 (en) 1976-10-02 1978-04-06 Dynamit Nobel Ag METHOD OF MANUFACTURING FUNCTIONAL CELLULOSES
US4175183A (en) 1977-03-01 1979-11-20 Development Finance Corporation Of New Zealand Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof
GB1594389A (en) 1977-06-03 1981-07-30 Max Planck Gesellschaft Dressing material for wounds
AT359653B (en) 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
AT359652B (en) 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
DE3036033A1 (en) 1980-09-24 1982-05-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen POWDERED WOUND TREATMENT AND METHOD FOR THE PRODUCTION THEREOF
US4793336A (en) 1981-03-25 1988-12-27 Wang Paul Y Wound coverings and processes for their preparation
EP0068047B1 (en) 1981-06-25 1986-07-23 Serapharm GmbH & Co. KG Enriched plasma derivative for promoting wound sealing and wound healing
US4405324A (en) 1981-08-24 1983-09-20 Morca, Inc. Absorbent cellulosic structures
DE3270438D1 (en) 1981-09-30 1986-05-15 Leipzig Arzneimittel Absorbent wound dressing and processes for its production
SE430218B (en) 1981-12-30 1983-10-31 Blombaeck E G B FILTER AND SET TO MAKE A SADANT
US5059654A (en) 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
SE437270B (en) 1983-07-19 1985-02-18 Pharmacia Ab SEPARATION MATERIAL OF THE CIRCUIT AGAROS AND ITS PREPARATION SEPARATION MATERIAL OF THE CIVIL-AGAROS AND ITS PREPARATION
US4549653A (en) 1983-09-06 1985-10-29 Johnson & Johnson Products, Inc. Adhesive bandage and package
SE460017B (en) 1984-03-14 1989-09-04 Landstingens Inkopscentral BACTERY-ADDRESSING COMPOSITION IN WATER-SOLUBLE FORM
US4738849A (en) 1984-06-28 1988-04-19 Interface Biomedical Laboratories Corp. Composite medical articles for application to wounds and method for producing same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
JPS61122222A (en) 1984-11-19 1986-06-10 Koken:Kk Hemostatic agent composed of collagen or gelatin and protamine
NO166836C (en) 1985-03-14 1991-09-11 Univ California PROCEDURE FOR TREATMENT OF AN ORGAN TRANSPLANT.
SE458525B (en) 1985-05-23 1989-04-10 Pharmacia Ab PROCEDURE FOR CROSS-BINDING OF A PORO'S AGAR OR AGARO GEL
US4616644A (en) 1985-06-14 1986-10-14 Johnson & Johnson Products, Inc. Hemostatic adhesive bandage
US4946953A (en) 1986-10-16 1990-08-07 Kanebo, Ltd. Fine cellulose particles and process for production thereof employing coagulated viscose
US5225047A (en) 1987-01-20 1993-07-06 Weyerhaeuser Company Crosslinked cellulose products and method for their preparation
US4777249A (en) 1987-03-13 1988-10-11 Teepak, Inc. Crosslinked cellulose aminomethanate
GB8705985D0 (en) 1987-03-13 1987-04-15 Geistlich Soehne Ag Dressings
GB8709498D0 (en) 1987-04-22 1987-05-28 Bay M Wound dressing
US4848329A (en) * 1987-09-01 1989-07-18 Herbert Dardik Mucoid absorbing dressing
JPH06104116B2 (en) 1988-11-29 1994-12-21 三菱化成株式会社 Wound dressing
US5077210A (en) 1989-01-13 1991-12-31 Eigler Frances S Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent
US5015476A (en) 1989-08-11 1991-05-14 Paravax, Inc. Immunization implant and method
US5185001A (en) 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
US5098417A (en) 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US5241009A (en) 1990-05-07 1993-08-31 Kimberly-Clark Corporation Polymeric composition containing carboxy nueutralized with lithium or potassium
NO171069C (en) 1990-05-29 1993-01-20 Protan Biopolymer As COVALENT CIRCUIT, STRONGLY SWELLING ALKALIMETAL AND AMMONIUM ALGINATE GELS, AND PROCEDURES FOR PREPARING THEREOF
US5196190A (en) 1990-10-03 1993-03-23 Zenith Technology Corporation, Limited Synthetic skin substitutes
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5279955A (en) 1991-03-01 1994-01-18 Pegg Randall K Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates
FR2679573B1 (en) 1991-07-25 1993-09-24 Perfojet Sa PROCESS FOR THE MANUFACTURE OF A WASHABLE, COTTON-BASED TABLECLOTH, AND TABLECLOTH THUS OBTAINED.
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US5584827A (en) 1992-05-18 1996-12-17 Ultracell Medical Technologies, Inc Nasal-packing article
US5521079A (en) 1994-01-24 1996-05-28 The Regents Of The University Of California Microcapsule generating system containing an air knife and method of encapsulating
US5578314A (en) 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
WO1994013266A1 (en) 1992-05-29 1994-06-23 The Regents Of The University Of California Novel electrostatic process for manufacturing coated transplants and products
US6001387A (en) 1992-05-29 1999-12-14 The Reguents Of The University Of California Spin disk encapsulation apparatus and method of use
US5643594A (en) 1992-05-29 1997-07-01 The Regents Of The University Of California Spin encapsulation apparatus and method of use
US5429821A (en) 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
AU4402793A (en) 1992-05-29 1993-12-30 Regents Of The University Of California, The Coated transplant and method for making same
US5470576A (en) * 1992-06-08 1995-11-28 The Kendall Company Process for preparing the alginate-containing wound dressing
CN1091315A (en) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 Fibrin sealant compositions and using method thereof
US5679372A (en) 1992-11-02 1997-10-21 Yasuhiko Shimizu Absorbable topical hemostat
GB9225581D0 (en) 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US5330974A (en) 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
DE69427716T2 (en) 1993-03-10 2002-06-13 Nichiban Kk Adhesive bandage for hemostasis
US5681579A (en) 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5328687A (en) 1993-03-31 1994-07-12 Tri-Point Medical L.P. Biocompatible monomer and polymer compositions
US5624669A (en) 1993-03-31 1997-04-29 Tri-Point Medical Corporation Method of hemostatic sealing of blood vessels and internal organs
EP0726749B1 (en) 1993-11-03 2004-08-11 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US5502092A (en) 1994-02-18 1996-03-26 Minnesota Mining And Manufacturing Company Biocompatible porous matrix of bioabsorbable material
US5406671A (en) 1994-02-25 1995-04-18 Green; Daniel K. Trowel
US5514377A (en) 1994-03-08 1996-05-07 The Regents Of The University Of California In situ dissolution of alginate coatings of biological tissue transplants
DE69530553T2 (en) 1994-05-13 2004-03-25 KURARAY CO., LTD, Kurashiki MEDICAL POLYMER GEL
US5502042A (en) 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5614204A (en) 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5733545A (en) 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US5795581A (en) 1995-03-31 1998-08-18 Sandia Corporation Controlled release of molecular components of dendrimer/bioactive complexes
US5643192A (en) 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
US5795570A (en) 1995-04-07 1998-08-18 Emory University Method of containing core material in microcapsules
EP0821573A4 (en) 1995-04-19 2000-08-09 St Jude Medical Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
DE19521324C1 (en) 1995-06-12 1996-10-31 Immuno Ag Tissue adhesive and use thereof as a hemostatic
US6121508A (en) * 1995-12-29 2000-09-19 3M Innovative Properties Company Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same
US5800372A (en) 1996-01-09 1998-09-01 Aerojet-General Corporation Field dressing for control of exsanguination
US5696101A (en) 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
DE69719754D1 (en) 1996-05-23 2003-04-17 Xoma Technology Ltd THERAPEUTIC USE OF BPI PROTEIN PRODUCTS IN PEOPLE WITH BREEDING THROUGH TRAUMA
US5811151A (en) 1996-05-31 1998-09-22 Medtronic, Inc. Method of modifying the surface of a medical device
US5834008A (en) 1996-09-19 1998-11-10 U.S. Biomaterials Corp. Composition and method for acceleration of wound and burn healing
US5844087A (en) 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US5817381A (en) 1996-11-13 1998-10-06 Agricultural Utilization Research Institute Cellulose fiber based compositions and film and the process for their manufacture
US6083522A (en) * 1997-01-09 2000-07-04 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US5846213A (en) 1997-06-16 1998-12-08 The University Of Western Ontario Cellulose membrane and method for manufacture thereof
WO1999001143A1 (en) * 1997-07-03 1999-01-14 Orquest, Inc. Cross-linked polysaccharide drug carrier
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
DE19813663A1 (en) * 1998-03-27 1999-10-07 Beiersdorf Ag Wound dressings for removing disruptive factors from wound fluid
US6200595B1 (en) * 1998-04-24 2001-03-13 Kuraray Co., Ltd. Medical adhesive
US6200328B1 (en) * 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
EP1210130A1 (en) * 1999-08-20 2002-06-05 Beaulieu, André Solid wound healing formulations containing fibronectin
US6391048B1 (en) * 2000-01-05 2002-05-21 Integrated Vascular Systems, Inc. Integrated vascular device with puncture site closure component and sealant and methods of use
KR100721752B1 (en) * 2000-01-24 2007-05-25 쿠라레 메디카루 가부시키가이샤 Water-swellable polymer gel and process for preparing the same
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543410A (en) * 1982-06-21 1985-09-24 Morca, Inc. Absorbent cellulosic base structures
US5081041A (en) * 1990-04-03 1992-01-14 Minnesota Mining And Manufacturing Company Ionic component sensor and method for making and using same
US5902877A (en) * 1994-09-21 1999-05-11 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent of interleukins, process for removing the same, and adsorber for the same
WO2000076533A1 (en) * 1999-06-10 2000-12-21 Fusion Medical Technologies, Inc. Hemoactive compositions and methods for their manufacture and use
WO2001005370A1 (en) * 1999-07-16 2001-01-25 Samyang Corporation Antiadhesion barriers containing water-soluble alginate and carboxymethyl cellulose as major components and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1469865A4 *

Also Published As

Publication number Publication date
AU2002361902A8 (en) 2003-07-24
MXPA04006438A (en) 2005-06-08
CA2471994A1 (en) 2003-07-17
AU2002361902A1 (en) 2003-07-24
US20030175327A1 (en) 2003-09-18
WO2003057072A8 (en) 2004-07-08
EP1469865A2 (en) 2004-10-27
JP2005514105A (en) 2005-05-19
EP1469865A4 (en) 2010-04-14
US20080020026A1 (en) 2008-01-24
US7101862B2 (en) 2006-09-05
US20060141018A1 (en) 2006-06-29
WO2003057072A2 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
WO2003057072A8 (en) Hemostatic compositions and methods for controlling bleeding
EP1430911A3 (en) Hemostatic wound dressing and fabric containing aldehyde-modified polysaccharide
TW200518789A (en) Deployable multifunctional hemostatic agent
WO2005081866A3 (en) Hemostatic agent for topical and internal use
TW200507807A (en) Deployable hemostatic agent
AU2002327666A1 (en) Adhesive bandage containing an antimicrobial and an hemostatic agent
MXPA01001510A (en) Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing.
WO2007027849A8 (en) Multiribbon nanocellulose as a matrix for wound healing
CA2308462A1 (en) Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
EP0815879A3 (en) Bioabsorbable medical devices from oxidized polysaccharides
WO1999015209A3 (en) Fibrin sponge
AU1699199A (en) Improved wound dressing device
CA2352296A1 (en) Collagen hemostatic fibers
GB2383047B (en) Polysaccharide fibres
WO2002024792A3 (en) Adhesive compositions including self-assembling molecules, adhesives, articles, and methods
WO2004012582A3 (en) Systems, methods, and compositions for achieving closure of suture sites
WO2002005800A3 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
BR9906477A (en) Enhanced platelet-enriched wound healing
AU2001233185A1 (en) Wound healing compositions and methods using tropoelastin and lysyl oxidase
WO1999043344A3 (en) Matrix protein compositions for wound healing
AU5761499A (en) Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
EP1190724B8 (en) Use of antifibrinolytic agents for preparing sponges, compresses or dressings
WO2000015248A3 (en) Growth factor-containing composition for healing tissue damage
AU2002351292A1 (en) Hemostatic agent delivery system
MXPA04008221A (en) Alginate foam compositions.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/006438

Country of ref document: MX

Ref document number: 2003557435

Country of ref document: JP

Ref document number: 2471994

Country of ref document: CA

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 29/2003 UNDER (71) REPLACE "ARES MEDICAL, INC." BY "ARES LABORATORIES, LLC."

WWE Wipo information: entry into national phase

Ref document number: 2002797532

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002797532

Country of ref document: EP